2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...
¡®¼± ³ÑÀº ÆÐ¹Ð¸®¡¯ ¾ÈÁ¤È¯ ¡°ÀÌÇý¿ø, º¸¾ç½Ä ÇØÁØ Àû ¾ø´Âµ¥¡¦... (2024-08-16)
¹ø°³ÀåÅÍ, °Å·¡ ¿©Á¤ÀÇ ¸ðµç ´Ü°è¿¡ AI ±â¼ú µµÀÔ (2025-01-05)
¿µÈ­ '¼¼»ó Âü ¿¹»Û ¿Àµå¸®' ±èÀ̰æ, Ä£±ÙÇÑ Àΰ£¹Ì ¹ß»ê (2024-11-04)
¿¡À̼ö½º, Â÷¼¼´ë ÄÚÆÄÀÏ·µ+ PC ¶óÀξ÷ ¹× °ÔÀÌ¹Ö ³ëÆ®ºÏ °ø°³ (2025-01-14)
ÇϳªÀºÇà, 2024³â Àü ±ÝÀ¶±Ç ÅðÁ÷¿¬±Ý Àû¸³±Ý Áõ°¡ 1À§ (2025-01-23)
¼¾µ÷, ÁÙ ¼­Áö ¾Ê´Â ǪµåÆ®·° ÁÖ¹® ¼Ö·ç¼Ç ¼Ò°³ (2024-12-01)
DDC Announces Strategy to Create Bitcoin Reserves and Appoin... (2025-04-04)
Äڷγª19 ¹é½Å¿¡ Àû¿ëµÈ Ç׿ø Ç÷§Æû ±â¼ú ¡®Çѱ¹ ƯÇã µî·Ï¡¯ (2024-12-19)
ÆÔÅØ, Çö´ë¸ðºñ½º ADAS Á¦Á¶ Inline Àåºñ ¼öÁÖ È®º¸ (2024-10-27)
AI¿Í °áÇÕÇÑ ½ºÅ¸Æ®¾÷ÀÇ ¹Ì·¡ Á¦½Ã (2023-10-05)
'½Å¶û¼ö¾÷¡¯ ½ÉÇüŹ-»ç¾ß, Ãâ»ê 2ÁÖ ¾ÕµÐ ÀÏ»óÀº? (2025-01-15)
ÇÁ¸®¹Ì¾ö ÇÇÆ®´Ï½º 'ÇÏÀÌ·¢½º °­³²±¸Ã»¿ªÁ¡' °³Á¡ (2024-08-27)
2024³â ¾ÏȣȭÆó ¹é¸¸ÀåÀÚ Æø¹ßÀûÀ¸·Î ¼ºÀå (2024-09-05)
ÀâÄÚ¸®¾Æ, '2024 À¯Æ©ºê ¿÷½º ¾î¿öµå' 2³â ¿¬¼Ó ¼ö»ó (2024-12-11)
LSÀÏ·ºÆ®¸¯, º£Æ®³² ºóÁî¾û »ê¾÷´ÜÁö Á¦Á¶±â¾÷ ´ë»ó ¼Ö·ç¼Ç »ç¾÷ (2024-10-28)
±¤ÁÖÁ¤º¸¹®È­»ê¾÷ÁøÈï¿ø, AI ´ëÇ¥ µµ½Ã Á¶¼º ¹ÚÂ÷ (2024-12-20)
'1939³âÇü º¥Æ²¸® ¸¶Å© V ½ºÆ÷Ã÷ ¼³·é' ±¹³» ÃÖÃÊ °ø°³ (2024-09-23)
New Study Finds Masimo SedLine¢ç Brain Function Monitoring O... (2025-06-23)
¼¼°è³ì»ö°æÁ¦Á¤»óȸÀÇ 2024, ³ì»ö ±ÝÀ¶ÀÇ Áß´ëÇÑ ¿ªÇÒ °­Á¶ (2024-10-11)
IBK±â¾÷ÀºÇà-µ¿±¹´ë â¾÷±â¼ú¿ø-À¥ÄɽÃ, â¾÷±â¾÷ ¼ºÀå Áö¿ø (2025-01-07)
Align Partners Submits Shareholder Proposals at Coway Co., L... (2025-02-20)
IFALPA Welcomes Global Aviation Leaders to Conference in Inc... (2025-04-05)
Kinaxis Celebrates Supply Chain Trailblazers with 2025 Custo... (2025-04-14)
ÇÕÁ¤ ÇϴñæÀÇ ¹ã±æ, ¿ì¸®°¡ »ì¸°´Ù (2024-11-25)
Á¦³×½Ã½º, ¡®GV70 Àüµ¿È­ ºÎºÐº¯°æ ¸ðµ¨¡¯ Ãâ½Ã (2025-01-17)
       [ÀÌÀü][1]....[388][389][390][391][392][393][394][395][396]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..